Patients with retinal vein occlusion may be at increased risk for certain cardiovascular conditions according to this 20-year multinational study. Source: AAO
New findings link certain gene loci to glaucoma in people of African ancestry, chemotherapies for lung cancer may increase keratitis risk, autonomous AI-based eye exams prove useful for children with diabetes, and nighttime outdoor artificial light is linked to AMD. Source: AAO
Identifying the risk factors for poor prognosis in eyes with exogenous endophthalmitis may help stave off visual impairment. Source: AAO
Despite being disproportionately affected by diabetes, Black, Asian, and Hispanic populations are not adequately represented in diabetic macular edema studies. Source: AAO
A clinical trial found that using half-dose photodynamic therapy or subthreshold micropulse laser resulted in similar improvements in central serous chorioretinopathy (CSCR). Source: AAO
The efficacy of bilateral inferior oblique (BIO) myectomy vs BIO recession, in combination with bilateral rectus recession, in children with V-pattern exotropia has not been well studied. Source: AAO
A small study found altered Pentacam readings and biomechanical features in many parents of children with keratoconus, suggesting possible heritability of the disease. Source: AAO
Some Alzheimer’s disease drugs may reduce the risk of AMD, the COVID-19 pandemic has a lasting impact on ophthalmology training, more green space at schools could reduce myopia incidence, and older women have a higher prevalence of dry eye. Source: AAO
A study of children who underwent surgery for unilateral nontraumatic cataract due to persistent fetal vasculature (PFV) found that 5 years after surgery, only a small percentage of eyes had achieved age-normal visual acuity. Source: AAO
This study investigated changes in utilization of glaucoma-related CPT codes before and after reimbursement cuts for angle-based stenting procedures were implemented. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »
